Skip to Content

181 Results Found

  • Review
  • Open Access
48 Citations
11,539 Views
16 Pages

MECP2-Related Disorders in Males

  • Ainhoa Pascual-Alonso,
  • Antonio F. Martínez-Monseny,
  • Clara Xiol and
  • Judith Armstrong

4 September 2021

Methyl CpG binding protein 2 (MECP2) is located at Xq28 and is a multifunctional gene with ubiquitous expression. Loss-of-function mutations in MECP2 are associated with Rett syndrome (RTT), which is a well-characterized disorder that affects mainly...

(This article belongs to the Special Issue Molecular Research on Rett Syndrome and Related Disorders: From the Past towards the Future 2.0)
  • Article
  • Open Access
22 Citations
4,476 Views
32 Pages

Differential Sensitivity of the Protein Translation Initiation Machinery and mTOR Signaling to MECP2 Gain- and Loss-of-Function Involves MeCP2 Isoform-Specific Homeostasis in the Brain

  • Marjorie Buist,
  • Nada El Tobgy,
  • Danilo Shevkoplyas,
  • Matthew Genung and ,
  • Annan Ali Sher,
  • Shervin Pejhan and
  • Mojgan Rastegar
  • + 2 authors+ 0 author

24 April 2022

Eukaryotic gene expression is controlled at multiple levels, including gene transcription and protein translation initiation. One molecule with key roles in both regulatory mechanisms is methyl CpG binding protein 2 (MeCP2). MECP2 gain- and loss-of-f...

(This article belongs to the Special Issue Transcriptional Regulatory Mechanisms in Health and Disease)
  • Article
  • Open Access
7 Citations
4,729 Views
26 Pages

9 December 2022

Methyl CpG binding protein 2 (MeCP2) is an epigenetic reader that binds to methylated CpG dinucleotides and regulates gene transcription. Mecp2/MECP2 gene has 4 exons, encoding for protein isoforms MeCP2E1 and MeCP2E2. MeCP2 plays key roles in neurod...

(This article belongs to the Special Issue Molecular Research on Rett Syndrome and Related Disorders: From the Past towards the Future 2.0)
  • Review
  • Open Access
80 Citations
22,208 Views
27 Pages

8 January 2021

Rett Syndrome (RTT) is a severe, rare, and progressive developmental disorder with patients displaying neurological regression and autism spectrum features. The affected individuals are primarily young females, and more than 95% of patients carry de ...

(This article belongs to the Collection DNA Methylation Dynamics in Health and Disease)
  • Feature Paper
  • Article
  • Open Access
18 Citations
4,993 Views
19 Pages

22 August 2021

Methyl CpG binding protein 2 (MeCP2) is the main DNA methyl-binding protein in the brain that binds to 5-methylcytosine and 5-hydroxymethyl cytosine. MECP2 gene mutations are the main origin of Rett Syndrome (RTT), a neurodevelopmental disorder in yo...

(This article belongs to the Collection DNA Methylation Dynamics in Health and Disease)
  • Review
  • Open Access
38 Citations
9,956 Views
26 Pages

MeCP2-Related Diseases and Animal Models

  • Chinelo D. Ezeonwuka and
  • Mojgan Rastegar

27 January 2014

The role of epigenetics in human disease has become an area of increased research interest. Collaborative efforts from scientists and clinicians have led to a better understanding of the molecular mechanisms by which epigenetic regulation is involved...

(This article belongs to the Special Issue Feature Papers)
  • Review
  • Open Access
30 Citations
5,464 Views
22 Pages

The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology

  • Kazem Nejati-Koshki,
  • Chris-Tiann Roberts,
  • Ghader Babaei and
  • Mojgan Rastegar

9 May 2023

Epigenetic mechanisms are gene regulatory processes that control gene expression and cellular identity. Epigenetic factors include the “writers”, “readers”, and “erasers” of epigenetic modifications such as DNA met...

(This article belongs to the Special Issue Oncogenes and Tumor Suppressor Genes in Brain Tumor)
  • Review
  • Open Access
81 Citations
14,933 Views
17 Pages

MeCP2: A Critical Regulator of Chromatin in Neurodevelopment and Adult Brain Function

  • Kubra Gulmez Karaca,
  • David V.C. Brito and
  • Ana M.M. Oliveira

16 September 2019

Methyl CpG binding protein 2 (MeCP2) was first identified as a nuclear protein with a transcriptional repressor role that recognizes DNA methylation marks. MeCP2 has a well-established function in neurodevelopment, as evidenced by the severe neurolog...

(This article belongs to the Special Issue Molecular Research on Rett Syndrome and Related Disorders: From the Past Towards the Future)
  • Review
  • Open Access
45 Citations
11,874 Views
27 Pages

Role of Mecp2 in Experience-Dependent Epigenetic Programming

  • Christoph A. Zimmermann,
  • Anke Hoffmann,
  • Florian Raabe and
  • Dietmar Spengler

6 March 2015

Mutations in the X-linked gene MECP2, the founding member of a family of proteins recognizing and binding to methylated DNA, are the genetic cause of a devastating neurodevelopmental disorder in humans, called Rett syndrome. Available evidence sugges...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
12 Citations
3,458 Views
18 Pages

A Comprehensive and Integrative Approach to MeCP2 Disease Transcriptomics

  • Alexander J. Trostle,
  • Lucian Li,
  • Seon-Young Kim,
  • Jiasheng Wang and ,
  • Rami Al-Ouran,
  • Hari Krishna Yalamanchili,
  • Zhandong Liu and
  • Ying-Wooi Wan
  • + 3 authors+ 0 author

Mutations in MeCP2 result in a crippling neurological disease, but we lack a lucid picture of MeCP2′s molecular role. Individual transcriptomic studies yield inconsistent differentially expressed genes. To overcome these issues, we demonstrate...

(This article belongs to the Section Molecular Neurobiology)
  • Review
  • Open Access
45 Citations
8,023 Views
31 Pages

MeCP2 and Chromatin Compartmentalization

  • Annika Schmidt,
  • Hui Zhang and
  • M. Cristina Cardoso

3 April 2020

Methyl-CpG binding protein 2 (MeCP2) is a multifunctional epigenetic reader playing a role in transcriptional regulation and chromatin structure, which was linked to Rett syndrome in humans. Here, we focus on its isoforms and functional domains, inte...

(This article belongs to the Special Issue Nuclear Architecture, Lipids, and Phase Separation)
  • Article
  • Open Access
35 Citations
7,635 Views
15 Pages

DNA Methylation Contributes to the Differential Expression Levels of Mecp2 in Male Mice Neurons and Astrocytes

  • Vichithra R.B. Liyanage,
  • Carl O. Olson,
  • Robby M. Zachariah,
  • James R. Davie and
  • Mojgan Rastegar

Methyl CpG binding protein-2 (MeCP2) isoforms (E1 and E2) are important epigenetic regulators in brain cells. Accordingly, MeCP2 loss- or gain-of-function mutation causes neurodevelopmental disorders, including Rett syndrome (RTT), MECP2 duplication...

(This article belongs to the Special Issue Molecular Research on Rett Syndrome and Related Disorders: From the Past Towards the Future)
  • Case Report
  • Open Access
11 Citations
4,116 Views
4 Pages

Rett Syndrome in Males: The Different Clinical Course in Two Brothers with the Same Microduplication MECP2 Xq28

  • Maria Bernarda Pitzianti,
  • Angelo Santamaria Palombo,
  • Susanna Esposito and
  • Augusto Pasini

Rett syndrome (RTT) is a neurodevelopmental disorder with a genetic basis that is associated with the mutation of the X-linked methyl-CpG binding protein 2 (MECP2) gene in approximately 90% of patients. RTT is characterized by a brief period of norma...

(This article belongs to the Section Children's Health)
  • Feature Paper
  • Article
  • Open Access
12 Citations
5,978 Views
15 Pages

Medical Comorbidities in MECP2 Duplication Syndrome: Results from the International MECP2 Duplication Database

  • Daniel Ta,
  • Jenny Downs,
  • Gareth Baynam,
  • Andrew Wilson and ,
  • Peter Richmond and
  • Helen Leonard
  • + 1 author+ 0 author

28 April 2022

Since the discovery of MECP2 duplication syndrome (MDS) in 1999, efforts to characterise this disorder have been limited by a lack of large datasets, with small case series often favouring the reporting of certain conditions over others. This study i...

(This article belongs to the Special Issue Challenges of Rare Diseases in Children)
  • Article
  • Open Access
11 Citations
4,640 Views
17 Pages

The Role of MECP2 and CCR5 Polymorphisms on the Development and Course of Systemic Lupus Erythematosus

  • Ewa Rzeszotarska,
  • Anna Sowinska,
  • Barbara Stypinska,
  • Ewa Walczuk and ,
  • Anna Wajda,
  • Anna Lutkowska,
  • Anna Felis-Giemza,
  • Marzena Olesinska,
  • Mariusz Puszczewicz and
  • Agnieszka Paradowska-Gorycka
  • + 11 authors+ 6 authors

24 March 2020

Systemic lupus erythematosus (SLE) is a chronic and systemic autoimmune disease. SLE is described by production of autoantibodies and causes damage of many organs. T-cells play a crucial role in SLE pathogenesis. T-cells intensify inflammation throug...

  • Feature Paper
  • Review
  • Open Access
38 Citations
8,506 Views
17 Pages

The Role of MeCP2 in Regulating Synaptic Plasticity in the Context of Stress and Depression

  • Carla L. Sánchez-Lafuente,
  • Lisa E. Kalynchuk,
  • Hector J. Caruncho and
  • Juan Ausió

21 February 2022

Methyl-CpG-binding protein 2 (MeCP2) is a transcriptional regulator that is highly abundant in the brain. It binds to methylated genomic DNA to regulate a range of physiological functions implicated in neuronal development and adult synaptic plastici...

(This article belongs to the Special Issue Transcriptional Regulatory Mechanisms in Health and Disease)
  • Article
  • Open Access
33 Citations
5,256 Views
18 Pages

23 March 2020

Background: Recurrence and distant organ metastasis is a major cause of death in colorectal cancer (CRC); however, the underlying molecular mechanisms regulating this phenomenon are poorly understood. MeCP2 is a key epigenetic regulator and is amplif...

  • Article
  • Open Access
4 Citations
4,252 Views
22 Pages

Unraveling Molecular Pathways Altered in MeCP2-Related Syndromes, in the Search for New Potential Avenues for Therapy

  • Alba-Aina Castells,
  • Rafel Balada,
  • Alba Tristán-Noguero,
  • Mar O’Callaghan and ,
  • Elisenda Cortès-Saladelafont,
  • Ainhoa Pascual-Alonso,
  • Àngels Garcia-Cazorla,
  • Judith Armstrong and
  • Soledad Alcántara
  • + 4 authors+ 0 author

Methyl-CpG-binding protein 2 (MeCP2) is an X-linked epigenetic modulator whose dosage is critical for neural development and function. Loss-of-function mutations in MECP2 cause Rett Syndrome (RTT, OMIM #312750) while duplications in the Xq28 locus co...

(This article belongs to the Section Neurobiology and Clinical Neuroscience)
  • Review
  • Open Access
51 Citations
15,305 Views
32 Pages

20 February 2023

DNA methylation, one of the most well-studied epigenetic modifications, is involved in a wide spectrum of biological processes. Epigenetic mechanisms control cellular morphology and function. Such regulatory mechanisms involve histone modifications,...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
2 Citations
2,617 Views
30 Pages

Mutation of MeCP2 at T158M Leads to Distinct Molecular and Phenotypic Abnormalities in Male and Female Mice

  • Chris-Tiann Roberts,
  • Ashraf Kadar Shahib,
  • Khatereh Saei Arezoumand,
  • Ghanan Bin Akhtar and ,
  • Kazem Nejati-Koshki,
  • Jessica S. Jarmasz,
  • Seyyed Mohyeddin Ziaee,
  • Marjorie Buist,
  • Nicole Raabe and
  • Mojgan Rastegar
  • + 7 authors+ 2 authors

19 August 2025

Methyl CpG-binding protein 2 (MeCP2) is an epigenetic reader of DNA methylation with high abundance in the brain. While genetic mutations occur across different protein domains of MeCP2, the T158M mutation is amongst the most frequent MeCP2 mutations...

(This article belongs to the Section Cellular Pathology)
  • Article
  • Open Access
29 Citations
8,700 Views
28 Pages

ATRX Contributes to MeCP2-Mediated Pericentric Heterochromatin Organization during Neural Differentiation

  • Domenico Marano,
  • Salvatore Fioriniello,
  • Francesca Fiorillo,
  • Richard J. Gibbons and ,
  • Maurizio D’Esposito and
  • Floriana Della Ragione
  • + 1 author+ 0 author

29 October 2019

Methyl-CpG binding protein 2 (MeCP2) is a multi-function factor involved in locus-specific transcriptional modulation and the regulation of genome architecture, e.g., pericentric heterochromatin (PCH) organization. MECP2 mutations are responsible for...

(This article belongs to the Special Issue Molecular Research on Rett Syndrome and Related Disorders: From the Past Towards the Future)
  • Review
  • Open Access
9 Citations
9,540 Views
30 Pages

26 August 2025

Rett syndrome is a severe neurodevelopmental disorder that occurs primarily in females and is caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene located on the X chromosome. Though MECP2 acts as a representative transcriptional regu...

(This article belongs to the Special Issue Molecular Advances in Pediatric Diseases)
  • Article
  • Open Access
12 Citations
5,054 Views
16 Pages

Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome

  • Yann Ehinger,
  • Valerie Matagne,
  • Valérie Cunin,
  • Emilie Borloz and ,
  • Michel Seve,
  • Sandrine Bourgoin-Voillard,
  • Ana Borges-Correia,
  • Laurent Villard and
  • Jean-Christophe Roux
  • + 4 authors+ 0 author

Mutations in the X-linked MECP2 gene are responsible for Rett syndrome (RTT), a severe neurological disorder. MECP2 is a transcriptional modulator that finely regulates the expression of many genes, specifically in the central nervous system. Several...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
4 Citations
2,384 Views
15 Pages

Adenosinergic System and BDNF Signaling Changes as a Cross-Sectional Feature of RTT: Characterization of Mecp2 Heterozygous Mouse Females

  • Catarina Miranda-Lourenço,
  • Jéssica Rosa,
  • Nádia Rei,
  • Rita F. Belo and ,
  • Ana Luísa Lopes,
  • Diogo Silva,
  • Cátia Vieira,
  • Teresa Magalhães-Cardoso,
  • Ricardo Viais and
  • Maria J. Diógenes
  • + 7 authors+ 2 authors

13 November 2023

Rett Syndrome is an X-linked neurodevelopmental disorder (RTT; OMIM#312750) associated to MECP2 mutations. MeCP2 dysfunction is seen as one cause for the deficiencies found in brain-derived neurotrophic factor (BDNF) signaling, since BDNF is one of t...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
2 Citations
2,297 Views
18 Pages

Transcriptional Consequences of MeCP2 Knockdown and Overexpression in Mouse Primary Cortical Neurons

  • Mostafa Rezapour,
  • Joshua Bowser,
  • Christine Richardson and
  • Metin Nafi Gurcan

17 September 2025

Rett syndrome (RTT) and MECP2 duplication syndrome, a subtype of autism spectrum disorder (ASD), are neurodevelopmental disorders caused by MeCP2 loss and gain of function, respectively. While MeCP2 is known to regulate transcription through its inte...

(This article belongs to the Special Issue Genes and Human Diseases: 3rd Edition)
  • Article
  • Open Access
30 Citations
11,144 Views
24 Pages

The Efficacy of a Human-Ready miniMECP2 Gene Therapy in a Pre-Clinical Model of Rett Syndrome

  • Chanchal Sadhu,
  • Christopher Lyons,
  • Jiyoung Oh,
  • Indumathy Jagadeeswaran and ,
  • Steven J. Gray and
  • Sarah E. Sinnett
  • + 1 author+ 0 author

24 December 2023

Inactivating mutations and the duplication of methyl-CpG binding protein 2 (MeCP2), respectively, mediate Rett syndrome (RTT) and MECP2 duplication syndrome. These disorders underscore the conceptual dose-dependent risk posed by MECP2 gene therapy fo...

(This article belongs to the Section Human Genomics and Genetic Diseases)
  • Article
  • Open Access
6 Citations
3,926 Views
17 Pages

Early Postnatal Treatment with Valproate Induces Gad1 Promoter Remodeling in the Brain and Reduces Apnea Episodes in Mecp2-Null Mice

  • Misa Ishiyama,
  • Satoko Tamura,
  • Hisanori Ito,
  • Hiroki Takei and ,
  • Manami Hoshi,
  • Masatake Asano,
  • Masayuki Itoh and
  • Tetsuo Shirakawa
  • + 3 authors+ 0 author

18 October 2019

The deletion of Mecp2, the gene encoding methyl-CpG-binding protein 2, causes severe breathing defects and developmental anomalies in mammals. In Mecp2-null mice, impaired GABAergic neurotransmission is demonstrated at the early stage of life. GABAer...

(This article belongs to the Section Molecular Informatics)
  • Article
  • Open Access
12 Citations
5,867 Views
14 Pages

Blood–Brain Barrier Integrity Is Perturbed in a Mecp2-Null Mouse Model of Rett Syndrome

  • Giuseppe Pepe,
  • Salvatore Fioriniello,
  • Federico Marracino,
  • Luca Capocci and ,
  • Vittorio Maglione,
  • Maurizio D’Esposito,
  • Alba Di Pardo and
  • Floriana Della Ragione
  • + 3 authors+ 0 author

28 March 2023

Rett syndrome (RTT, online MIM 312750) is a devastating neurodevelopmental disorder characterized by motor and cognitive disabilities. It is mainly caused by pathogenetic variants in the X-linked MECP2 gene, encoding an epigenetic factor crucial for...

(This article belongs to the Section Molecular Medicine)
  • Article
  • Open Access
1 Citations
2,264 Views
14 Pages

Alternative splicing is one of the processes that contributes to producing a vast protein diversity from the limited number of protein-coding genes in higher eukaryotes. The Methyl CpG Binding Protein 2 (Mecp2) gene, whose mutations cause Rett syndro...

(This article belongs to the Special Issue RNA Biology and Regulation)
  • Feature Paper
  • Review
  • Open Access
6 Citations
5,768 Views
25 Pages

23 December 2024

Background: Neurodevelopmental disorders (NDDs) affect approximately 15% of children and adolescents worldwide. This group of disorders is often polygenic with varying risk factors, with many associated genes converging on shared molecular pathways,...

(This article belongs to the Special Issue The Genetic and Epigenetic Basis of Neurodevelopmental Disorders)
  • Article
  • Open Access
1,568 Views
15 Pages

Metformin Treatment Shows Beneficial Effects on RTT-Associated Phenotypical Deficits in Mecp2 T158M Male Mice

  • Khatereh Saei Arezoumand,
  • Ghanan Bin Akhtar,
  • Ashraf Kadar Shahib,
  • Jessica S. Jarmasz and ,
  • Chris-Tiann Roberts,
  • Abbas Rezaeian Mehrabadi,
  • Carl O. Olson and
  • Mojgan Rastegar
  • + 3 authors+ 0 author

15 April 2026

Background: Rett Syndrome (RTT) is a progressive neurodevelopmental disorder caused by MECP2 gene mutations. MeCP2 protein binding to methylated DNA is involved in normal brain development and function. T158M is a common RTT-associated mutation, wher...

(This article belongs to the Section Pharmacology)
  • Review
  • Open Access
1,363 Views
20 Pages

Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder that is caused in most cases by pathogenic variants in MECP2, the gene encoding methyl-CpG-binding protein 2 (MeCP2). Despite substantial progress in the development of gene therapy...

(This article belongs to the Section Clinical Applications of Non-Coding RNA)
  • Article
  • Open Access
3 Citations
2,171 Views
12 Pages

27 February 2026

Background/Objectives: Factors modulating phenotypic variability in Rett syndrome (RTT, OMIM 312750) include X chromosome inactivation (XCI), type of MECP2 variant, and/or disease modifiers. Emerging evidence also points to multi-locus genetic varian...

(This article belongs to the Special Issue Feature Papers in "Neurogenetics and Neurogenomics": 2026)
  • Article
  • Open Access
16 Citations
7,018 Views
24 Pages

MECP2 Increases the Pro-Inflammatory Response of Microglial Cells and Phosphorylation at Serine 423 Regulates Neuronal Gene Expression upon Neuroinflammation

  • Rebekka Wittrahm,
  • Mari Takalo,
  • Mikael Marttinen,
  • Teemu Kuulasmaa and ,
  • Petra Mäkinen,
  • Susanna Kemppainen,
  • Henna Martiskainen,
  • Tuomas Rauramaa,
  • Ian Pike and
  • Mikko Hiltunen
  • + 8 authors+ 3 authors

9 April 2021

Methyl-CpG-binding protein 2 (MECP2) is a critical transcriptional regulator for synaptic function. Dysfunction of synapses, as well as microglia-mediated neuroinflammation, represent the earliest pathological events in Alzheimer’s disease (AD). Here...

(This article belongs to the Section Cellular Neuroscience)
  • Review
  • Open Access
17 Citations
15,940 Views
21 Pages

Rett Syndrome and the Role of MECP2: Signaling to Clinical Trials

  • Adele Gaspar Lopes,
  • Sampath Kumar Loganathan and
  • Jayalakshmi Caliaperumal

24 January 2024

Rett syndrome (RTT) is a neurological disorder that mostly affects females, with a frequency of 1 in 10,000 to 20,000 live birth cases. Symptoms include stereotyped hand movements; impaired learning, language, and communication skills; sudden loss of...

(This article belongs to the Section Molecular and Cellular Neuroscience)
  • Article
  • Open Access
8 Citations
3,894 Views
18 Pages

Prognostic Impact of Genetic Variants of MECP2 and TIRAP on Clinical Outcomes of Systemic Lupus Erythematosus with and without Nephritis

  • Safaa I. Tayel,
  • Nashwa M. Muharram,
  • Dina S. Fotoh,
  • Hany S. Elbarbary and ,
  • Huda I. Abd-Elhafiz,
  • Eman A. El-Masry,
  • Ahmed E. Taha and
  • Shimaa E. Soliman
  • + 3 authors+ 0 author

18 September 2021

Systemic lupus erythematosus (SLE) is a chronic autoimmune illness with a growing prevalence in many populations. Few studies have examined genetic predisposition to SLE, so we aimed to examine the clinical impact of the genetic polymorphisms MECP2 r...

  • Article
  • Open Access
2 Citations
2,841 Views
11 Pages

17 June 2024

Background and Objectives: This study aimed to investigate the relationship between neuropathic pain and CREB-binding protein (CBP) and methyl-CpG-binding protein 2 (MeCP2) expression levels in a rat model with spared nerve injury (SNI). Materials an...

(This article belongs to the Section Orthopedics)
  • Article
  • Open Access
13 Citations
4,371 Views
15 Pages

Music-Based Intervention Ameliorates Mecp2-Loss-Mediated Sociability Repression in Mice through the Prefrontal Cortex FNDC5/BDNF Pathway

  • Pi-Lien Hung,
  • Kay L. H. Wu,
  • Chih-Jen Chen,
  • Ka-Kit Siu and ,
  • Yi-Jung Hsin,
  • Liang-Jen Wang and
  • Feng-Sheng Wang
  • + 2 authors+ 0 author

Patients with Rett syndrome (RTT) show severe difficulties with communication, social withdrawl, and learning. Music-based interventions improve social interaction, communication skills, eye contact, and physical skills and reduce seizure frequency i...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
1,710 Views
21 Pages

23 February 2026

Chromatin organization during postnatal development is very important for establishing neuronal function and may be disrupted in neurodevelopmental disorders that are associated with impaired brain function. Both the Methyl CpG-binding protein 2 (MeC...

(This article belongs to the Special Issue Molecular Advances in Rett Syndrome and Other Chromatin Related Disorders)
  • Article
  • Open Access
5 Citations
3,823 Views
20 Pages

MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping

  • Martina Mietto,
  • Silvia Montanari,
  • Maria Sofia Falzarano,
  • Elisa Manzati and ,
  • Paola Rimessi,
  • Marina Fabris,
  • Rita Selvatici,
  • Francesca Gualandi,
  • Marcella Neri and
  • Alessandra Ferlini
  • + 12 authors+ 7 authors

Rett syndrome (RTT) is a rare X-linked dominant neurodevelopmental disorder caused by pathogenic variants in the methyl-CpG-binding protein 2 (MECP2) gene, which encodes a methyl-CpG-binding protein (MeCP2) that acts as a repressor of gene expression...

(This article belongs to the Special Issue Molecular Advances in Rett Syndrome and Other Chromatin Related Disorders)
  • Article
  • Open Access
8 Citations
4,007 Views
17 Pages

21 April 2024

Rett Syndrome (RTT) is a progressive X-linked neurodevelopmental disorder with no cure. RTT patients show disease-associated symptoms within 18 months of age that include developmental regression, progressive loss of useful hand movements, and breath...

(This article belongs to the Special Issue Brain-Derived Neurotrophic Factor in Health and Diseases)
  • Article
  • Open Access
11 Citations
3,818 Views
18 Pages

Molecular Context-Dependent Effects Induced by Rett Syndrome-Associated Mutations in MeCP2

  • David Ortega-Alarcon,
  • Rafael Claveria-Gimeno,
  • Sonia Vega,
  • Olga C. Jorge-Torres and ,
  • Manel Esteller,
  • Olga Abian and
  • Adrian Velazquez-Campoy
  • + 2 authors+ 0 author

10 November 2020

Methyl-CpG binding protein 2 (MeCP2) is a transcriptional regulator and a chromatin-binding protein involved in neuronal development and maturation. Loss-of-function mutations in MeCP2 result in Rett syndrome (RTT), a neurodevelopmental disorder that...

(This article belongs to the Special Issue The Amazing World of IDPs in Human Diseases)
  • Article
  • Open Access
3 Citations
3,468 Views
14 Pages

Circulating 4-F4t-Neuroprostane and 10-F4t-Neuroprostane Are Related to MECP2 Gene Mutation and Natural History in Rett Syndrome

  • Cinzia Signorini,
  • Silvia Leoncini,
  • Thierry Durand,
  • Jean-Marie Galano and ,
  • Alexandre Guy,
  • Valérie Bultel-Poncé,
  • Camille Oger,
  • Jetty Chung-Yung Lee,
  • Lucia Ciccoli and
  • Claudio De Felice
  • + 6 authors+ 1 author

Neuroprostanes, a family of non-enzymatic metabolites of the docosahexaenoic acid, have been suggested as potential biomarkers for neurological diseases. Objective biological markers are strongly needed in Rett syndrome (RTT), which is a progressive...

(This article belongs to the Special Issue Updates on Mechanisms and Markers of Oxidative Stress in Neurological Diseases)
  • Article
  • Open Access
950 Views
15 Pages

Dysregulated Cholesterol Clearance via CYP46A1 Contributes to Cerebellar Sterol Imbalance in Mecp2-Null Mice

  • Pablo J. Tapia,
  • Bastian I. Rivera,
  • C. Sofía Espinoza,
  • Francisca Stolzenbach and ,
  • María J. Yáñez and
  • Bredford Kerr
  • + 1 author+ 0 author

Rett syndrome (RTT) is a neurodevelopmental disorder characterized by motor deficits, partly attributed to cerebellar dysfunction. RTT is primarily caused by mutations in the gene encoding the methyl-CpG-binding protein 2 (MECP2), which has been impl...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
6 Citations
5,358 Views
20 Pages

How Families Manage the Complex Medical Needs of Their Children with MECP2 Duplication Syndrome

  • Dani John Cherian,
  • Daniel Ta,
  • Jeremy Smith,
  • Jenny Downs and
  • Helen Leonard

11 July 2023

MECP2 duplication syndrome (MDS) is a rare, X-linked, neurodevelopmental disorder resulting from the duplication of the methyl-CpG-binding protein 2 (MECP2) gene. The clinical features of MDS include severe intellectual disability, global development...

(This article belongs to the Section Pediatric Nursing)
  • Article
  • Open Access
9 Citations
8,469 Views
18 Pages

Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage

  • Tina Khorshid Ahmad,
  • Ting Zhou,
  • Khaled AlTaweel,
  • Claudia Cortes and ,
  • Ryan Lillico,
  • Ted Martin Lakowski,
  • Kiana Gozda and
  • Michael Peter Namaka
  • + 3 authors+ 0 author

Multiple sclerosis (MS) is a chronic neurological disease characterized by the destruction of central nervous system (CNS) myelin. At present, there is no cure for MS due to the inability to repair damaged myelin. Although the neurotrophin brain deri...

(This article belongs to the Special Issue Brain-Derived Neurotrophic Factor)
  • Article
  • Open Access
4 Citations
3,761 Views
13 Pages

Development of an International Database for a Rare Genetic Disorder: The MECP2 Duplication Database (MDBase)

  • Daniel Ta,
  • Jenny Downs,
  • Gareth Baynam,
  • Andrew Wilson and ,
  • Peter Richmond,
  • Aron Schmidt,
  • Amelia Decker and
  • Helen Leonard
  • + 3 authors+ 0 author

25 July 2022

The natural history of MECP2 duplication syndrome (MDS), a rare X-linked neurodevelopmental disorder with an estimated birth prevalence of 1/150,000 live births, is poorly understood due to a lack of clinical data collected for research. Such informa...

(This article belongs to the Special Issue New Insight in Neurodevelopmental Disorders in Children)
  • Article
  • Open Access
21 Citations
4,626 Views
24 Pages

21 September 2021

Using unsupervised metabolomics, we defined the complex metabolic conditions in the cortex of a mouse model of Rett syndrome (RTT). RTT, which represents a cause of mental and cognitive disabilities in females, results in profound cognitive impairmen...

(This article belongs to the Special Issue Molecular and Cellular Mechanisms of Rare Diseases)
  • Feature Paper
  • Article
  • Open Access
15 Citations
3,810 Views
18 Pages

Stabilization Effect of Intrinsically Disordered Regions on Multidomain Proteins: The Case of the Methyl-CpG Protein 2, MeCP2

  • David Ortega-Alarcon,
  • Rafael Claveria-Gimeno,
  • Sonia Vega,
  • Olga C. Jorge-Torres and ,
  • Manel Esteller,
  • Olga Abian and
  • Adrian Velazquez-Campoy
  • + 2 authors+ 0 author

16 August 2021

Intrinsic disorder plays an important functional role in proteins. Disordered regions are linked to posttranslational modifications, conformational switching, extra/intracellular trafficking, and allosteric control, among other phenomena. Disorder pr...

(This article belongs to the Special Issue The Amazing World of IDPs in Human Diseases II)
  • Article
  • Open Access
5 Citations
2,816 Views
13 Pages

This study aimed to investigate the impact of caloric restriction (CR) on cognitive function in aged C57BL/6 mice after surgery, as well as the underlying mechanisms. Forty 14-month-old male C57BL/6 mice were randomly assigned to the ad libitum (AL,...

(This article belongs to the Section Cognitive, Social and Affective Neuroscience)

of 4